Less Ads, More Data, More Tools Register for FREE

Pin to quick picksExperian Regulatory News (EXPN)

Share Price Information for Experian (EXPN)

Share Price is delayed by 15 minutes
Get Live Data
2,619.00    -20.00 (-0.76%)
Bid:
2,621.00
Ask:
2,625.00
Spread: 4.00 (0.153%)
Market Cap: £23.39b
EXPN Live PriceLast checked at - London Stock Exchange

Intraday Experian Share Chart

Directorate Change

12 Feb 2025 07:00

RNS Number : 7574W
Experian plc
12 February 2025
Β 

Experian plc

Β 

Β 

Directorate Change

Β 

Β 

12 February 2025 - Experian plc, the global data and technology company, announces the appointment of a new independent Non-Executive Director to the Board of Experian plc, effective from 1 March 2025.

Β 

Eduardo Vassimon, a Brazilian national, is Chair of Votorantim S.A., a privately-owned investment holding company. With more than 35 years' prior experience in financial services, Eduardo has combined senior executive roles at Itaú Unibanco (where he was the Chief Executive Officer of Banco Itaú BBA and led the Wholesale Bank for the Group, having previously been the Group Chief Financial Officer and Group Chief Risk Officer) with more entrepreneurial activities/ventures, including at Fundo Pitanga. He was previously a director of B3, one of the world's largest financial market infrastructure companies, where he chaired the risk and financial committee, and of TOTVS S.A., Brazil's largest technology company, where he chaired the nomination and corporate governance committee.

Β 

Mike Rogers, Chair of Experian, commented:

Β 

"I am delighted to welcome Eduardo to the Experian Board. His appointment is another strong addition for us, bringing his significant experience from the financial services sector, Experian's largest vertical, as well as his deep knowledge of the Brazilian market. Eduardo also adds further financial expertise. We are excited to welcome Eduardo to the Experian Board, and we look forward to working with him."

Β 

The Company confirms, save for Eduardo Vassimon's previous directorships of B3 and TOTVS S.A., that there are no details to be disclosed under UK Listing Rule 6.4.8R, paragraphs (1) to (6) in respect of his appointment.

Β 

Contact:

Experian

Nadia Ridout-Jamieson Investor queries +44 (0)20 3042 4220

Nick Jones Media queries +44 (0)79 7673 4702

Β 

Teneo

Graeme Wilson and Louise Male +44 (0)20 7353 4200

Β 

About Experian

Experian is a global data and technology company, powering opportunities for people and businesses around the world. We help to redefine lending practices, uncover and prevent fraud, simplify healthcare, deliver digital marketing solutions, and gain deeper insights into the automotive market, all using our unique combination of data, analytics and software. We also assist millions of people to realise their financial goals and help them to save time and money.

We operate across a range of markets, from financial services to healthcare, automotive, agrifinance, insurance, and many more industry segments.

We invest in talented people and new advanced technologies to unlock the power of data and innovate. As a FTSE 100 Index company listed on the London Stock Exchange (EXPN), we have a team of 22,500 people across 32 countries. Our corporate headquarters are in Dublin, Ireland. Learn more at experianplc.com.

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
BOATBMLTMTTBBFA
Date   Source Headline
10th Feb 20267:00 amRNSTransaction in Own Shares
9th Feb 20265:05 pmRNSDirector/PDMR Shareholding
9th Feb 20267:00 amRNSTransaction in Own Shares
6th Feb 20267:00 amRNSTransaction in Own Shares
5th Feb 20261:00 pmRNSDirector/PDMR Shareholding
5th Feb 20267:00 amRNSTransaction in Own Shares
4th Feb 20267:00 amRNSTransaction in Own Shares
3rd Feb 20267:00 amRNSTransaction in Own Shares
2nd Feb 20267:00 amRNSTransaction in Own Shares
30th Jan 20262:49 pmRNSTotal Voting Rights
30th Jan 20267:00 amRNSCapital allocation update
27th Jan 20261:30 pmRNSDirector/PDMR Shareholding
21st Jan 20267:00 amRNSTrading update, third quarter
16th Jan 20265:39 pmRNSFirst interim dividend
16th Jan 202611:41 amRNSBlock listing Return
8th Jan 20267:00 amRNSExperian plc Chair Announcement
31st Dec 202511:23 amRNSTotal Voting Rights
31st Dec 202511:23 amRNSTotal Voting Rights
19th Dec 202510:08 amRNSElections for first interim dividend
19th Dec 202510:08 amRNSElections for first interim dividend
1st Dec 20257:00 amRNSTransaction in Own Shares
28th Nov 202512:35 pmRNSTotal Voting Rights
28th Nov 20257:00 amRNSTransaction in Own Shares
27th Nov 20257:00 amRNSTransaction in Own Shares
26th Nov 20255:15 pmRNSHolding(s) in Company
26th Nov 20257:00 amRNSTransaction in Own Shares
25th Nov 20257:00 amRNSTransaction in Own Shares
24th Nov 20257:00 amRNSTransaction in Own Shares
14th Nov 20259:30 amRNSDirector/PDMR Shareholding
13th Nov 20259:30 amRNSDirector/PDMR Shareholding
12th Nov 20257:00 amRNSHalf-year Financial Report
31st Oct 202511:18 amRNSTotal Voting Rights
14th Oct 20251:00 pmRNSExperian – US mortgage market update
1st Oct 202510:24 amRNSAdditional Listing
30th Sep 202511:41 amRNSTotal Voting Rights
29th Sep 20257:00 amRNSTransaction in Own Shares
26th Sep 20257:00 amRNSTransaction in Own Shares
25th Sep 20257:00 amRNSTransaction in Own Shares
24th Sep 20259:23 amRNSAdditional Listing
24th Sep 20257:00 amRNSTransaction in Own Shares
23rd Sep 20257:00 amRNSTransaction in Own Shares
18th Sep 202510:07 amRNSBlock listing Interim Review
16th Sep 20257:00 amRNSTransaction in Own Shares
15th Sep 202510:00 amRNSDirector Declaration
15th Sep 20257:00 amRNSTransaction in Own Shares
12th Sep 20257:00 amRNSTransaction in Own Shares
11th Sep 20257:00 amRNSTransaction in Own Shares
8th Sep 20257:00 amRNSTransaction in Own Shares
5th Sep 20257:00 amRNSTransaction in Own Shares
4th Sep 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.